These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9274131)

  • 41. Procedure guideline for breast scintigraphy. Society of Nuclear Medicine.
    Khalkhali I; Diggles LE; Taillefer R; Vandestreek PR; Peller PJ; Abdel-Nabi HH
    J Nucl Med; 1999 Jul; 40(7):1233-5. PubMed ID: 10405150
    [No Abstract]   [Full Text] [Related]  

  • 42. First Clinical Experience Using Stereotactic Breast Biopsy Guided by
    Collarino A; Olmos RAV; Neijenhuis PA; den Hartog WC; Smit F; de Geus-Oei LF; Arias-Bouda LMP
    AJR Am J Roentgenol; 2017 Dec; 209(6):1367-1373. PubMed ID: 28379735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Delpassand ES; Jackson EF
    Radiology; 1997 Oct; 205(1):283-4; author reply 285-6. PubMed ID: 9315002
    [No Abstract]   [Full Text] [Related]  

  • 44. 99mTc-MIBI scintimammography using a dedicated nuclear mammograph.
    Maini CL; de Notaristefani F; Tofani A; Iacopi F; Sciuto R; Semprebene A; Malatesta T; Vittori F; Frezza F; Botti C; Giunta S; Natali PG
    J Nucl Med; 1999 Jan; 40(1):46-51. PubMed ID: 9935055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
    Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
    Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
    Waxman AD
    J Nucl Med; 1997 Nov; 38(11):1778-80. PubMed ID: 9374353
    [No Abstract]   [Full Text] [Related]  

  • 47. A study on the cost effectiveness of sestamibi scintimammography for screening women with dense breasts for breast cancer.
    Allen MW; Hendi P; Bassett L; Phelps ME; Gambhir SS
    Breast Cancer Res Treat; 1999 Jun; 55(3):243-58. PubMed ID: 10517169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The usefulness of Tc-99m sestamibi scintimammography in the diagnosis of squamous cell carcinoma of the breast.
    Ohta H; Saito T; Yamamoto S; Ukikusa M; Awane H; Shintaku M
    Clin Nucl Med; 1998 Sep; 23(9):617-8. PubMed ID: 9735988
    [No Abstract]   [Full Text] [Related]  

  • 49. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
    Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
    Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility and reproducibility of semiquantitative analysis of sestamibi breast images.
    Dunnwald LK; Hartnett SD; Mankoff DA
    J Nucl Med Technol; 1997 Jun; 25(2):106-9. PubMed ID: 9239613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography.
    Scopinaro F; Schillaci O; Ussof W; Nordling K; Capoferro R; De Vincentis G; Danieli R; Ierardi M; Picardi V; Tavolaro R; Colella AC
    Anticancer Res; 1997; 17(3B):1631-4. PubMed ID: 9179208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of patient positioning in scintimammography.
    Mirzaei S
    Eur J Nucl Med; 2001 Jul; 28(7):941-2. PubMed ID: 11504096
    [No Abstract]   [Full Text] [Related]  

  • 53. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of external radioactive markers in scintimammography.
    Klein M; Weininger J; Moshe S; Peretz T; Chisin R
    Clin Nucl Med; 2001 Jan; 26(1):10-3. PubMed ID: 11139045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast Cancer Imaging: Can Tc-99m Sestamibi Scintimammography Fit In?
    Iraniha S; Khalkhali I; Cutrone JA; Diggles L; Klein SR
    Medscape Womens Health; 1997 Apr; 2(4):2. PubMed ID: 9746689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard.
    Chen SL; Yin YQ; Chen JX; Sun XG; Xiu Y; Liu WG; Liu M; Zhu WM; Zhang YB
    Anticancer Res; 1997; 17(3B):1695-8. PubMed ID: 9179221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
    Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
    Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement.
    Schillaci O; Scopinaro F; Danieli R; Tavolaro R; Picardi V; Cannas P; Colella AC
    Nucl Med Commun; 1997 Sep; 18(9):839-45. PubMed ID: 9352550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Gammography using Tc 99m MIBI in patients with suspected breast cancer. Proposed diagnostic protocol].
    Prats E; Abós M; Aisa F; Villavieja L; Asenjo M; García-López F; Tomás A; Sainz J; Razola P; Banzo J
    Rev Esp Med Nucl; 1998; 17(2):73-81. PubMed ID: 9611276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Invited commentary: one step forward.
    Lastoria S; Piccolo S; Muto P
    J Nucl Med; 2002 Jul; 43(7):916-7. PubMed ID: 12097462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.